Enoxaparin in Acute Venous Thromboembolic Disease

Inclusion Criteria: * Patients with symptomatic lower-extremity deep venous thrombosis confirmed by doppler USG (ultrasonography), with or without confirmed symptomatic pulmonary embolism associated with provoked risk factors Exclusion Criteria: * Patients with a history of heparin or warfarin treatment longer than 24 hours, * Patients requiring thrombolytic treatment, * Patients having thrombophilia diagnosis, * Patients with prior deep vein thrombosis or pulmonary emboli evidence, * Patients with familial bleeding disorder, * Patients who are at any known bleeding risk, such as active bleeding, active ulcerative bowel disease, angiodysplasia and having oculary, spinal or central nervous system surgery within the last month * Patients with renal failure (serum creatinine concentration \> 180 mmol/L or \> 2.03 mg/dL), * Patients with severe hepatic failure * Patients with history of allergy against heparin and protamine, * Patients with history of thrombocytopenia associated with heparin administration or of skin necrosis after heparin or warfarin treatment, * Patients participating in another clinical study within the last 4 months * Patients who are pregnant The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.